array(13) { ["code"]=> string(2) "en" ["id"]=> string(1) "1" ["native_name"]=> string(2) "US" ["major"]=> string(1) "1" ["active"]=> string(1) "1" ["default_locale"]=> string(2) "en" ["encode_url"]=> string(1) "0" ["tag"]=> string(2) "en" ["missing"]=> int(0) ["translated_name"]=> string(2) "US" ["url"]=> string(108) "https://www.prosigna.com/en/resource/prosigna-breast-cancer-assay-now-approved-for-reimbursement-in-germany/" ["country_flag_url"]=> string(87) "https://www.prosigna.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png" ["language_code"]=> string(2) "en" } native: US
translated: US
IN the US OUTSIDE the US
CONTACT US

Contact us today

Monday to Friday, 5:30 AM – 5:00 PM (PST)

Phone: 1.888.923.4762

International: +1.650.243.6335

Fax: 650.243.6388

info@prosigna.com

You are now entering a page intended for healthcare professionals only, if you are a patient or a member of the public, we will address you to a dedicated webpage.
Live-Webinar – 21st December: Cost savings associated with using Prosigna®
REGISTER NOW